Synovate Launches Indian Oncology Monitor (India)
This article was originally published in PharmAsia News
Executive Summary
Synovate Healthcare has recently announced the startup of a new branch of their oncology monitoring system, to be based in India. The Synovate Healthcare India Oncology Monitor will follow pharmaceutical prescribing practices in major cancer treatment centers all over the country. Already, Synovate has monitors in 11 countries, including China, Korea, and Australia, which were launched last year. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.